| Pharmaceutical active ingredients: |
| Gadoxetic Acid (Gadoxetate Disodium) |
| Available forms, composition and doses of Eovist: |
| Injectable; Injection; Gadoxetic Acid (Gadoxetate Disodium) 181.43 mg / ml |
| Eovist medical category: |
| Human:Contrast agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08CA10 - Gadoxetic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Related documents and information about Eovist: |
| Eovist prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dotarem | Gadoteric Acid (Meglumine Gadoterate) | Guerbet; A. Martins & Fernandes; Aspen Pharmacare; Codali; Gothia Medical; ProMedico; R + N Farmakevtika; Rider Laboratorios; Temis Lostalo Laboratorios; WL-Medical |
| ProHance | Gadoteridol | Bracco; Altana Pharma; Astra Tech; Bristol-Myers Squibb; Byk; Eisai; Gerot Pharmazeutika; Merck; Nycomed; Regional Health Care Products Group; Rovi Laboratorios |
| ProHance Multipack | Gadoteridol | Bracco; Nycomed |
| OptiMARK | Gadoversetamide | Mallinckrodt; Tyco Healthcare |
| OptiMARK in plastic container | Gadoversetamide | Mallinckrodt; Tyco Healthcare |
| Primovist | Gadoxetic Acid (Gadoxetate Sodium) | Bayer Schering Pharma |
| Primovist PFS | Gadoxetic Acid (Gadoxetate Sodium) | Bayer Schering Pharma |
| IRS 19 Tablets | Gaffkya Tetragena; Haemophilus Influenzae; Klebsiella Pneumoniae; Micrococcus Pyogenes; Moraxella; Moraxella Catarrhalis; Neisseria Flava; Neisseria Perflava; Streptococcus Groups A, C, D, G; Streptococcus Pneumoniae | Solvay |
| Bucovacuna | Gaffkya Tetragena; Haemophilus Influenzae; Klebsiella Pneumoniae; Micrococcus Pyogenes; Moraxella; Moraxella Catarrhalis; Streptococcus Pneumoniae | Solvay |
| Brain Sugar | Galactose | Unidentified Pharmaceutical Company |